Screener
Evommune EVMN Q3 2025 earnings
Reported December 11, 2025 · Before market open
Revenue$10.0MBeat by $6.7M
EPS-$8.07Miss by $1.99
Revenue estimate$3.3M
EPS estimate-$6.08
Next report
Date not yet announcedVersus estimates
Revenue
Q3 2025$10.0MBeat by $6.7M
Diluted EPS
Q3 2026-$0.85Miss by $0.02Q2 2026-$0.89Miss by $0.23Q1 2026-$0.64Beat by $0.19Q4 2025-$1.43Miss by $0.61
Q3 2025-$8.07Miss by $1.99
FAQ
- When did Evommune report Q3 2025 earnings?
- Evommune (EVMN) reported Q3 2025 earnings on December 11, 2025 before market open.
- What were Evommune's Q3 2025 revenue and EPS?
- Evommune reported revenue of $10.0M and eps of $-8.07 for Q3 2025.
- Did Evommune beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $3.3M by $6.7M. EPS missed the consensus estimate of $-6.08 by $1.99.
- Where can I find Evommune's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-315918) and the 10-Q periodic report (0001193125-25-315972) directly on SEC EDGAR. The filing index links above go to sec.gov.
